Device
caIMR
caIMR is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Trials by Status
recruiting125%
completed250%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruiting
A Clinical Study of Fundus OCTA for the Identification of CMD
NCT05743140
not_yet_recruiting
A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.
NCT06945094
completed
SHR Predicts CMD in Patients with CCS
NCT06698432
completed
Prognostic Significance of CMD Assessed by IMR in HCM Patients
NCT06190704
Clinical Trials (4)
Showing 4 of 4 trials
NCT05743140
A Clinical Study of Fundus OCTA for the Identification of CMD
NCT06945094
A Multi-center, Real-World Clinical Trial of caIMR on Two Specific Kinds of Patients.
NCT06698432
SHR Predicts CMD in Patients with CCS
NCT06190704
Prognostic Significance of CMD Assessed by IMR in HCM Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4